ACRX - AcelRx Pharmaceuticals Stock Trading

Tetraphase Pharmaceuticals ( TTPH -11.1% ) has entered into a second amendment of its merger agreement with AcelRx Pharmaceuticals ( ACRX ) after the latter submitted a revised bid of $0.5872 in cash plus 0.7409 in ACRX stock, representing an offer of ~$1.70 per share ($37M), topping Mel...

Signaling its determination to close the deal amid rival offers, AcelRx Pharmaceuticals ( ACRX -4.0% ) has increased its bid for Tetraphase Pharmaceuticals ( TTPH -8.3% ) to $30M in cash and stock plus an additional $14.5M in cash payable under a contingent value right (CVR). More news...

REDWOOD CITY, Calif. , May 27, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the execution of ...